Skip to main content

Advertisement

Table 4 Demographic features of subjects evaluated in this study

From: Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA

Demographic   Clinical diagnosis of prospectively enrolled patients
CRCb Gastric cancer Liver cancer AAa NAa Hyperplastic/other polyp NEDb
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Sex Male 133 (54.3) 9 (39.1) 8 (80.0) 2 (66.7) 22 (53.7) 12 (66.7) 114 (46.5)
Female 112 (45.7) 14 (60.9) 2 (20.0) 1 (33.3) 19 (46.3) 6 (33.3) 131 (53.5)
Age ≤ 49 36 (14.7) 9 (39.1) 1 (10.0) 11 (26.8) 4 (22.2) 87 (35.5)
50–59 62 (25.3) 7 (30.4) 5 (50.0) 1 (33.3) 17 (41.5) 9 (50.0) 105 (42.9)
60–69 79 (32.2) 5 (21.7) 3 (30.0) 2 (66.7) 12 (29.3) 5 (27.8) 47 (19.2)
≥ 70 68 (27.8) 2 (8.7) 1 (10.0) 1 (2.4) 6 (2.4)
Total   245 23 10 3 41 18 245
  1. aAA advanced adenomas (≥ 1.0 cm), NA non-advanced adenomas (< 1.0 cm)
  2. bCRC colorectal cancer, NED no evidence of disease